During the past decade, David Cantu de Leon conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "David Cantu de Leon" are "Cervix Cancer" (2 trials), "Cervical Cancer" (1 trials) and "Gynecologic Cancer" (1 trials). Many other conditions were trialed in "David Cantu de Leon" in a lesser frequency.

Most popular intervention types in "David Cantu de Leon" are "Radiation" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Genetic signature" (1 trials), "Hypofractionated therapy" (1 trials), "Radical hysterectomy" (1 trials), "Standard radiotherapy" (1 trials) and "Standard therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "David Cantu de Leon" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "David Cantu de Leon". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in David Cantu de Leon, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in David Cantu de Leon, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".